ANPEP and cancer: Finally, CD13 is considered a viable target for cancer therapy [10, 28] in view of its participation in processes such as angiogenesis, tumor cell migration, and invasiveness, and the fact that expression of CD13 is dysregulated in several types of cancer cells, contributing in several ways to the malignancy.